As Executive Vice President, Chief Business and Strategy Officer, Dr. Nicholas Donoghoe leads Business Development and Acquisitions, Search and Evaluation, Global Alliances, Corporate Strategy and Innovation and Transformation. Dr. Donoghoe is focused on establishing strategies and partnerships across the development continuum that will benefit patients and fuel scientific progress. Additionally, he is dedicated to building new internal capabilities that help deliver remarkable therapies to our patients more efficiently and effectively.
Dr. Donoghoe previously held leadership roles across R&D and Commercial, in both AbbVie’s Therapeutic and Aesthetic businesses. He was a partner at McKinsey & Co and has an M.D. from Johns Hopkins School of Medicine.